Pemetrexed in combination with cisplatin or carboplatin as adjuvant chemotherapy in early-stage NSCLC

被引：0
作者：
Schmid-Bindert, G.
Chemaissani, A.
Fischer, J. R.
Schuette, W.
Mazieres, J.
Vinolas, N.
Wolf, M.
Vaury, A. Thareau
Leschinger, M.
Reck, M.
机构：
[1] Univ Heidelberg, Univ Ctr Mannheim, D-6800 Mannheim, Germany
[2] Lung Clin Cologne Merheim, Cologne, Germany
[3] Klinikum Loewenstein gGmbH, Loewenstein, Germany
[4] Hosp Martha Maria, Halle Doelau, Germany
[5] Larrey Hosp, Toulouse, France
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Klinikum Kassel Med Kilin IV, Kassel, Germany
[8] Lilly France, Suresnes, France
[9] Lilly Deutschland GmbH, Bad Homburg, Germany
[10] Hosp Grosshansdorf, Grosshansdorf, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7565
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Cisplatin/carboplatin combination as neoadjuvant chemotherapy for cervical cancer
    Hasuo, Y
    Sugiyama, T
    Iwanaga, S
    Yakushiji, M
    [J]. 10TH INTERNATIONAL MEETING OF GYNAECOLOGICAL ONCOLOGY, 1997, : 159 - 163
  • [42] Carboplatin-Pemetrexed Adjuvant Chemotherapy in Resected Non-small Cell Lung Cancer (NSCLC): A Phase II Study
    Karapanagiotou, Eleni M.
    Boura, Paraskevi G.
    Papamichalis, George
    Konstantinou, Marios
    Sepsas, Evangellos
    Chamalakis, George
    Simsiris, Panagiotis
    Gkiozos, Ioannis
    Syrigos, Kostas N.
    [J]. ANTICANCER RESEARCH, 2009, 29 (10) : 4297 - 4301
  • [43] Pemetrexed (Pem) in combination with cisplatin (CP) or rarboplatin (CB) for stage IV NSCLC: A single -institution experience.
    Ponce Aix, Santiago
    Blazquez, Maria
    Iglesias, Lara
    Nunez, Juan A.
    Zugazagoltla, Jon
    Munoz, Cesar
    Parrilla, Lucia
    Pernaut, Cristina
    Otero, Irene
    Andres, Eva
    Cortes-Funes, Hernan
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [44] Uptake and tolerance of adjuvant chemotherapy in early stage NSCLC patients in Alberta, Canada
    Winget, Marcy
    Fleming, John
    Li, Xue
    Gao, Zhiwei
    Butts, Charles
    [J]. LUNG CANCER, 2011, 72 (01) : 52 - 58
  • [45] The Role of Lymphadenectomy in Early-Stage NSCLC
    Manfredini, Beatrice
    Zirafa, Carmelina Cristina
    Filosso, Pier Luigi
    Stefani, Alessandro
    Romano, Gaetano
    Davini, Federico
    Melfi, Franca
    [J]. CANCERS, 2023, 15 (14)
  • [46] The Role of Radiotherapy in Early-Stage NSCLC
    Senan, Suresh
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S42 - S43
  • [47] The Use of Biomarkers in Early-Stage NSCLC
    Kim, Jae Y.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2023, 21 (03) : 131 - 133
  • [48] ADJUVANT CHEMOTHERAPY WITH CISPLATIN, DOXORUBICIN, AND CYCLOPHOSPHAMIDE (PAC) FOR EARLY-STAGE HIGH-RISK ENDOMETRIAL CANCER - A PRELIMINARY-ANALYSIS
    STRINGER, CA
    GERSHENSON, DM
    BURKE, TW
    EDWARDS, CL
    GORDON, AN
    WHARTON, JT
    [J]. GYNECOLOGIC ONCOLOGY, 1990, 38 (03) : 305 - 308
  • [49] Combination chemotherapy including ifosfamide, carboplatin, and cisplatin in advanced non-small cell lung cancer (NSCLC)
    Sorensen, JB
    Larsen, H
    Hansen, HH
    [J]. EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1108 - 1108
  • [50] Does adjuvant chemotherapy improve survival for women with early-stage uterine leiomyosarcoma?
    Ricci, Stephanie
    Giuntoli, Robert L., II
    Eisenhauer, Eric
    Lopez, Micael A.
    Krill, Lauren
    Tanner, Edward J., III
    Gehrig, Paola A.
    Havrilesky, Laura J.
    Secord, Angeles Alvarez
    Levinson, Kimberly
    Frasure, Heidi
    Celano, Paul
    Fader, Amanda Nickles
    [J]. GYNECOLOGIC ONCOLOGY, 2013, 131 (03) : 629 - 633
12345